3,743
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

An Over-the-Counter Central Sensitization Therapy: A Chronic Back Pain Registry Study of Pain Relief, Medication Use and Their Adverse Effects

, &
Pages 99-111 | Received 27 Sep 2016, Accepted 23 Nov 2016, Published online: 02 Dec 2016

References

  • Tennant F , HermannL . Intractable or chronic pain: there is a difference . West. J. Med.173 ( 5 ), 306 ( 2000 ).
  • Baker M , CollettB , FischerAet al. Pain Proposal: Improving the Current and Future Management of Chronic Pain. A European Concensus Report. ( 2010 ). www.dgss.org/fileadmin/pdf/Pain_Proposal_European_Consensus_Report.pdf .
  • Breivik H , CollettB , VentafriddaV , CohenR , GallacherD . Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment . Eur. J. Pain10 ( 4 ), 287 – 333 ( 2006 ).
  • Gaskin DJ , RichardP . The economic costs of pain in the United States . J. Pain13 ( 8 ), 715 – 724 ( 2012 ).
  • Hong J , ReedC , NovickD , HappichM . Costs associated with treatment of chronic low back pain: an analysis of the UK General Practice Research Database . Spine (Phila Pa 1976)38 ( 1 ), 75 – 82 ( 2013 ).
  • Phillips CJ . The cost and burden of chronic pain . Rev. Pain3 ( 1 ), 2 – 5 ( 2009 ).
  • Belsey J . Primary care workload in the management of chronic pain: a retrospective cohort study using a GP database to identify resource implications for UK primary care . J. Med. Econ.5 ( 1–4 ), 39 – 50 ( 2002 ).
  • Dale R , StaceyB . Multimodal treatment of chronic pain . Med. Clin. North Am.100 ( 1 ), 55 – 64 ( 2016 ).
  • Mathews M . Multimodal treatment of pain . Neurosurg. Clin. N. Am.25 ( 4 ), 803 – 808 ( 2014 ).
  • Mathews M , DavinS . Chronic pain rehabilitation . Neurosurg. Clin. N. Am.25 ( 4 ), 799 – 802 ( 2014 ).
  • Saragiotto BT , MachadoGC , FerreiraML , PinheiroMB , Abdel ShaheedC , MaherCG . Paracetamol for low back pain . Cochrane Database Syst. Rev.6 , CD012230 ( 2016 ).
  • Enthoven WT , RoelofsPD , DeyoRA , Van TulderMW , KoesBW . Non-steroidal anti-inflammatory drugs for chronic low back pain . Cochrane Database Syst. Rev.2 , CD012087 ( 2016 ).
  • Moore RA , DerryS , AldingtonD , ColeP , WiffenPJ . Amitriptyline for neuropathic pain in adults . Cochrane Database Syst. Rev.7 , CD008242 ( 2015 ).
  • Rej S , DewMA , KarpJF . Treating concurrent chronic low back pain and depression with low-dose venlafaxine: an initial identification of ‘easy-to-use’ clinical predictors of early response . Pain Med.15 ( 7 ), 1154 – 1162 ( 2014 ).
  • Vyvey M . Steroids as pain relief adjuvants . Can. Fam. Physician56 ( 12 ), 1295 – 1297 , e1415 ( 2010 ).
  • Wiffen P , CollinsS , McquayH , CarrollD , JadadA , MooreA . Anticonvulsant drugs for acute and chronic pain . Cochrane Database Syst. Rev.3 , CD001133 ( 2005 ).
  • Wiffen PJ , McquayHJ , EdwardsJE , MooreRA . Gabapentin for acute and chronic pain . Cochrane Database Syst. Rev.3 , CD005452 ( 2005 ).
  • Deyo RA , Von KorffM , DuhrkoopD . Opioids for low back pain . BMJ350 , g6380 ( 2015 ).
  • Carter GT , DuongV , HoS , NgoKC , GreerCL , WeeksDL . Side effects of commonly prescribed analgesic medications . Phys. Med. Rehabil. Clin. N. Am.25 ( 2 ), 457 – 470 ( 2014 ).
  • Labianca R , Sarzi-PuttiniP , ZuccaroSM , CherubinoP , VellucciR , FornasariD . Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain . Clin. Drug Investig.32 ( Suppl. 1 ), 53 – 63 ( 2012 ).
  • Woodcock J . A difficult balance – pain management, drug safety, and the FDA . N. Engl. J. Med.361 ( 22 ), 2105 – 2107 ( 2009 ).
  • Foundation USP . Educating consumers on choosing and using OTC pain relievers responsibly . www.uspainfoundation.org/awareness/ .
  • Dworkin RH , TurkDC . Accelerating the development of improved analgesic treatments: the ACTION public-private partnership . Pain Med.12 ( Suppl. 3 ), S109 – S117 ( 2011 ).
  • Arthritis UK . New survey highlights severe impact of arthritis pain on daily life – but there is hope . www.arthritisresearchuk.org/news/press-releases/2016/april/new-survey-highlights-severe-impact-of-arthritis-pain-on-daily-life.aspx .
  • Koneru SN , WestgateCR , McLeodKJ . Rectification of RF fields in load dependent coupled systems: application to non-invasive electroceuticals . J. Biomed. Sci. Eng.9 , 112 – 121 ( 2016 ).
  • Bagnato GL , MiceliG , MarinoN , SciortinoD , BagnatoGF . Pulsed electromagnetic fields in knee osteoarthritis: a double blind, placebo-controlled, randomized clinical trial . Rheumatology (Oxford)55 ( 4 ), 755 – 762 ( 2016 ).
  • Brook J , DauphineeDM , KorpinenJ , RaweIM . Pulsed radiofrequency electromagnetic field therapy: a potential novel treatment of plantar fasciitis . J. Foot Ankle Surg.51 ( 3 ), 312 – 316 ( 2012 ).
  • Rawe IM , LowensteinA , BarceloCR , GenecovDG . Control of postoperative pain with a wearable continuously operating pulsed radiofrequency energy device: a preliminary study . Aesthetic Plast. Surg.36 ( 2 ), 458 – 463 ( 2012 ).
  • Rawe IM , KotakDC . A UK registry study of the effectiveness of a new over-the-counter chronic pain therapy . Pain Manag.5 ( 6 ), 413 – 423 ( 2015 ).
  • Carvalho C , CaetanoJM , CunhaL , ReboutaP , KaptchukTJ , KirschI . Open-label placebo treatment in chronic low back pain: a randomized controlled trial . Pain157 ( 12 ), 2766 – 2772 ( 2016 ).
  • Gillespie JI , Van KoeveringeGA , De WachterSG , De VenteJ . On the origins of the sensory output from the bladder: the concept of afferent noise . BJU Int.103 ( 10 ), 1324 – 1333 ( 2009 ).
  • Clauw DJ . Diagnosing and treating chronic musculoskeletal pain based on the underlying mechanism(s) . Best Pract. Res. Clin. Rheumatol.29 ( 1 ), 6 – 19 ( 2015 ).
  • Nijs J , Paul Van WilgenC , Van OosterwijckJ , Van IttersumM , MeeusM . How to explain central sensitization to patients with ‘unexplained’ chronic musculoskeletal pain: practice guidelines . Man. Ther.16 ( 5 ), 413 – 418 ( 2011 ).
  • Reynolds WS , DmochowskiR , WeinA , BruehlS . Does central sensitization help explain idiopathic overactive bladder?Nat. Rev. Urol.13 ( 8 ), 481 – 491 ( 2016 ).
  • Woolf CJ . Central sensitization: implications for the diagnosis and treatment of pain . Pain152 ( Suppl. 3 ), S2 – S15 ( 2011 ).
  • Mior S . Exercise in the treatment of chronic pain . Clin. J. Pain17 ( Suppl. 4 ), S77 – S85 ( 2001 ).
  • Schwartz N , TemkinP , JuradoSet al. Chronic pain. Decreased motivation during chronic pain requires long-term depression in the nucleus accumbens . Science345 ( 6196 ), 535 – 542 ( 2014 ).
  • Dailey DL , RakelBA , VanceCGet al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia . Pain154 ( 11 ), 2554 – 2562 ( 2013 ).
  • Desantana JM , Da SilvaLF , De ResendeMA , SlukaKA . Transcutaneous electrical nerve stimulation at both high and low frequencies activates ventrolateral periaqueductal grey to decrease mechanical hyperalgesia in arthritic rats . Neuroscience163 ( 4 ), 1233 – 1241 ( 2009 ).
  • Kalra A , UrbanMO , SlukaKA . Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS) . J. Pharmacol. Exp. Ther.298 ( 1 ), 257 – 263 ( 2001 ).
  • Ma YT , SlukaKA . Reduction in inflammation-induced sensitization of dorsal horn neurons by transcutaneous electrical nerve stimulation in anesthetized rats . Exp. Brain Res.137 ( 1 ), 94 – 102 ( 2001 ).
  • Bartley EJ , KingCD , SibilleKTet al. Enhanced pain sensitivity among individuals with symptomatic knee osteoarthritis: potential sex differences in central sensitization . Arthritis Care Res. (Hoboken)68 ( 4 ), 472 – 480 ( 2016 ).
  • Campbell CM , BuenaverLF , FinanPet al. Sleep, pain catastrophizing, and central sensitization in knee osteoarthritis patients with and without insomnia . Arthritis Care Res. (Hoboken)67 ( 10 ), 1387 – 1396 ( 2015 ).
  • Lluch E , TorresR , NijsJ , Van OosterwijckJ . Evidence for central sensitization in patients with osteoarthritis pain: a systematic literature review . Eur. J. Pain18 ( 10 ), 1367 – 1375 ( 2014 ).
  • Rawe I . A registry study to assess the durability of ActiPatch® – a novel OTC neuromodulation therapy for chronic pain . Br. J. Pain10 ( 2 Suppl. 1 ), 62 – 63 ( 2016 ).